Home532637 • BOM
Mangalam Drugs and Organics Ltd
add
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (INR) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 727.77M | -28.61% |
Operating expense | 319.58M | -2.27% |
Net income | 594.00K | -98.32% |
Net profit margin | 0.08 | -97.69% |
Earnings per share | — | — |
EBITDA | 96.06M | 5.50% |
Effective tax rate | 96.37% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (INR) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 25.89M | 118.07% |
Total assets | 3.66B | 9.81% |
Total liabilities | 2.17B | 9.87% |
Total equity | 1.49B | — |
Shares outstanding | 14.85M | — |
Price to book | 0.88 | — |
Return on assets | — | — |
Return on capital | 5.54% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (INR) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | 594.00K | -98.32% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
Previous close
₹88.75
Day range
₹84.94 - ₹90.75
Year range
₹65.50 - ₹144.65
Market cap
1.36B INR
Avg Volume
5.90K
P/E ratio
20.24
Dividend yield
-
Primary exchange
NSE
About
Founded
1972
Website
Employees
432
